Lectures & Presentations

Lectures & Presentations

Lectures are individual presentation on a topic in the field of expertise. Lectures from prior RePORT India annual conferences are not included, but are available upon request. Presentations & Abstracts are by multiple authors and include posters and oral discussions.

year 2022

year 2020

year 2019

year 2018

year 2017

Year 2022

slides

Year 2020

  1. Kamakshi Prudhula Devalraju, Venkata Sanjeev Kumar Neela, Mohammad Soheb Ansari, Ramakrishna Vankayalapati, Vijaya Lakshmi Valluri. Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection. Poster Presented at: RePORT International 2020 Annual Meeting. Mumbai, India; February 10–12, 2020.
  2. Venkata Sanjeev Kumar Neela, Kamakshi Prudhula Devalraju, Mohammad Soheb Ansari, Ramakrishna Vankayalapati, Vijaya Lakshmi Valluri. Memory like NK cells and monocytes as Immunological markers for protection in house hold contacts of tuberculosis patients. Poster Presented at: RePORT International 2020 Annual Meeting. Mumbai, India; February 10–12, 2020.
  3. Radhakrishnan RK, Thandi RS, Tripathi D, Paidipally P, McAllister MK, Mulik S, Samten B, Vankayalapati R. BCG vaccination reduces the mortality of Mycobacterium tuberculosis-infected type 2 diabetes mellitus (T2DM) mice. RePORT India 9th Annual Joint Leadership Meeting: Next Gen RePORT. Mumbai, India: February 10-12, 2020.
  4. Tornheim JA, Paradkar M, Fukutani F, Kinikar A, Mave V, Andrade BB, Gupta A, Karakousis PC. Blood-Based Biomarkers of Tuberculosis in Children Integrating Metabolomic and Transcriptomic Data. TB Science. Virtual. October 2020.
  5. Tornheim, JA. Identification of Blood-Based Biomarkers for Tuberculosis in Children using Integration of Metabolomics and Transcriptomics. TB RiCC Virtual Meeting. 29 September 2020.
  6. Queiroz ATL, Kulkarni V, Sangle S, Cordeiro-Santos M, Andrade BB, Sterling T, Gupta A, Ellner J, Kadam D, Rolla VC, Salgame P, Mave V. Transcriptome signature of tuberculosis in persons with advanced HIV from India. TB RiCC Virtual Meeting. 29 September 2020.
  7. Newman JW, Hanna LE, Queiroz ATL, Borkowski K, Gupte AN, Paradkar M, Satyamurthi P, Kulkarni V, Selva M, Pradhan N, Shivakumar SVBY, Natarajan S, Karunaianatham R, Gupte N, Thiruvengadam K, Fiehn O, Bharadwaj R, Kagal A, Gaikwad S, Sangle S, Golub JE, Andrade BB, Mave V. Host Lipidome Predicts Tuberculosis Treatment Outcomes. TB RiCC Virtual Meeting. 28 September 2020.
  8. Mathad JS. An RNA signature for tuberculosis risk in pregnant women: a prospective cohort study from India. TB RiCC Virtual Meeting. September 28-30, 2020.
  9. Tornheim JA, Madugundu AK, Paradkar M, Fukutani KF, Queiroz ATL, Gupte N, Gupte AN, Kinikar A, Kulkarni V, Balasubramanian U, Sreenivasamurthy S, Raja R, Pradhan N, Shivakumar SVBY, Valvi C, Hanna LE, Andrade BB, Mave V, Pandey A, Gupta A. Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response among Indian Children. Presented at: Johns Hopkins Department of Medicine Research Retreat. 28 February 2020. Baltimore, MD.
  10. Cox SR, Padmapriyadarsini C, Gaikwad S, Kinikar A, Shivakumar SVBY, Paradkar M, Sekar K, Gupte A, Seth B, Thiruvengadam K, Raskar S, Pradhan N, Kulkarni V, Hanna LE, Gupte N, Bollinger RC, Mave V, Gupta A, for the CTRIUMPH-RePORT India Study Team. Causes and timing of death among patients treated for tuberculosis in Pune and Chennai, India. Presented at: RePORT India Conference. 10-12 February 2020. Mumbai, India & Johns Hopkins Department of Medicine Research Retreat. 28 February 2020. Baltimore, MD.
  11. Christopher DJ. COVID TB WEBINAR. Trajectory of the Pandemic and Projected Disease Burden. Presented at: Webinar session Live on July 27, 2020.
  12. Christopher DJ. Smoking, alcohol, air pollution & TB. TB RiCC Virtual Meeting. September 28-30, 2020.
  13. D. J. Christopher, Dhivya Roy, Deepa Shankar, Balamugesh T Advance lung function testing: Lung Volumes(TLC) & Diffusing Capacity(DLco) diagnoses substantial pulmonary function impairment in treated Pulmonary Tuberculosis patients (24071) Presented at Virtual ERS International Congress 2020, Barcelona, Spain; September 7 to 9 2020.
  14. D. J. Christopher, Coelho Victor, Dr. Ebby Simon, Deepa Shankar, Balamugesh T Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extrapulmonary tuberculosis (25062) ) Presented at Virtual ERS International Congress 2020, Barcelona, Spain; September 7 to 9 2020.
  15. DJ Christopher, Roy D, Shankar D, Balamugesh T. Total lung and diffusing capacity in treated pulmonary tuberculosis patients. Presented at: RePORT India 2020 Joint Leadership Meeting. PD Hinduja, Mumbai; February 9 to 12, 2020.
  16. DJ Christopher, Rajasekar. S, Balamugesh T. Is smear microscopy obsolete in the era of Xpert MTB/Rif? Presented at: RePORT India 2020 Joint Leadership Meeting. PD Hinduja, Mumbai ; February 9 to 12, 2020.
  17. Santhosh S, DJChristopher, Winston B, Prabha R, Mathew S, Shankar D, Susan Mathew B. Dried plasma spots as a replacement for conventional plasma rifampicin concentration for use in resource limited settings Presented at: RePORT India 2020 Joint Leadership Meeting. PD Hinduja, Mumbai; February 9 to 12, 2020.
  18. Solomon R, Christudass CS, Shankar D, Thangakunam B, Christopher DJ. A sensitive PCR – Restriction Fragment Length Polymorphism (RFLP) method for the detection of leukotriene A4 hydrolase (LTA4H) rs17525495 genotyping. RePORT India 9th Annual Joint Leadership Meeting: Next Gen RePORT. Mumbai, India: February 10-12, 2020.
  19. Roy D, Christopher DJ. Thangakunam B. A study on lung function impairment in patients with pulmonary tuberculosis and changes with treatment. RePORT India 9th Annual Joint Leadership Meeting: Next Gen RePORT. Mumbai, India: February 10-12, 2020.
  20. Hochberg, NS. Malnutrition and TB. TB RiCC Virtual Meeting. September 28-30, 2020.
  21. Sinha P, Lönnroth K, Bhargava A, Sarkar S, Salgame P, Heysell SK, and Rudgard W. Food for thought: Undernutrition and Tuberculosis. Symposium, 50th Union World Lung Health Conference. Hyderabad, India. October 2020.
  22. VanValkenburg A, Kaipilyawar V, Sarkar S, Lakshminarayanan S, Cintron C, Babu S, Knudsen S, Joseph N, Horsburgh CR , Babu P, Ellner J, Johnson WE, Salgame P, Hochberg NS. Malnutrition is associated with increased inflammation and increased tuberculosis risk signatures in individuals with latent Mycobacterium tuberculosis infection. 2020.
    Kaipilyawar V, Verma S, Stringari LL, Ellner JJ, Alland D, Dietze R, Ribeiro-Rodrigues R, Salgame P. Innate immune mechanisms of protection against Mycobacterium tuberculosis infection. RePORT India 9th Annual Joint Leadership Meeting: Next Gen RePORT. Mumbai, India: February 10-12, 2020.
  23. Nancy, A, Kumar NP, Moideen K, Viswanathan V, Dhanasekaran M, Sivakumar S, Hissar S, Kornfeld H, Babu S. Metformin use is associated with diminished plasma cytokines/ chemokines and acute phase proteins in incident tuberculosis with known diabetes mellitus. RePORT India 9th Annual Joint Leadership Meeting: Next Gen Report. Mumbai, India: February 10-12, 2020.
    Devarajan A, Kumpatla S, Dhanasekaran M, Sahukar SB, Babu S, Kornfeld H, ViswanathanV. Glycaemic status in screen detected versus known cases of DM TB patients and its effect on treatment outcomes: EDOTS Study from South India. RePORT India 9th Annual Joint Leadership Meeting: Next Gen RePORT. Mumbai, India: February 10-12, 2020.
  24. Kumar NP, Nancy A, Moideen K, Viswanathan V, Dhanasekaran D, Sivakumar S, Hissar S, Kornfeld H, Babu S. Elevated unstimulated and TB antigen stimulated levels of IL-36 isoforms in tuberculosis-diabetes comorbidity. RePORT India 9th Annual Joint Leadership Meeting: Next Gen RePORT. Mumbai, India: February 10-12, 2020.
    Rodrigues C. Targeted NGS in TB diagnosis. TB RiCC Virtual Meeting. September 28-30, 2020.
  25. Udwadia ZF. India’s COVID response: The Good and The Bad. COVID TB Webinar, RePORT India. July 27 2020.
  26. Chawla PK, Keny Bhamini, Dherai AJ, Udwadia ZF, Mahashur AA, Pinto L, Soman R, Sunavala A, Mullerpattan J, Rodrigues C, Gupta A, Tornheim JA, Martison N, Ebraham V, Ashavaid TF. Serum linezolid levels in MDRTB patients. Abstract submitted at: RICC 2020, September 2020
  27. Chawla PK, Naik PR, Lokhande RV, Dherai AJ, Udwadia ZF, Mahashur AA, Pinto L, Mullerpattan J, Sunavala A, Soman R, Rodrigues C, Gupta A, Tornheim JA, Martinson N, Variava E, Wiesner L, Joubert A, Ashavaid TF. Development & validation of plasma Bedaquiline levels. Presented at: 33rd Annual Research Day, P.D. Hinduja Hospital and MRC. Mumbai, India; June 30, 2020. (Awarded 1st Prize for Best Laboratory paper).
  28. Naik PR, Chawla PK, Lokhande RV, Dherai AJ, Udwadia ZF, Mahashur AA, Pinto L, Mullerpattan J, Sunavala A, Soman R, Rodrigues C, Gupta A, Tornheim JA, Martinson N, Variava E, Wiesner L, Joubert A, Ashavaid TF. Plasma moxifloxacin levels in Indian MDR-TB patients. Presented at: 33rd Annual Research Day, P.D. Hinduja Hospital and MRC. Mumbai, India; June 30, 2020. (Awarded 2nd Prize for Best Laboratory paper)
  29. Tornheim JA, Gajjar I, Shivakumar SVBY, Gupte AN, Gutpe N, Kishore G, Karane M, Rodrigues C, Gupta A, Udwadia ZF. Increased Moxifloxacin Dosing among MDR-TB Patients with Low-Level Resistance to Moxifloxacin did not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India. Presented at: Johns Hopkins Department of Medicine Research Retreat. 28 February 2020. Baltimore, MD.
  30. Naik PR, Chawla PK, Lokhande RV, Dherai AJ, Udwadia ZF, Mahashur AA, Pinto L, Mullerpattan J, Sunavala A, Soman R, Rodrigues C, Gupta A, Tornheim JA, Martinson N, Variava E, Wiesner L, Joubert A, Ashavaid TF. Therapeutic Drug Monitoring of moxifloxacin in Indian MDR-TB patients. Presented at: RePORT India 9th Annual Joint Leadership Meeting: NEXT GEN RePORT, Mumbai, India, February 10-12, 2020.
  31. Gajjar I, Kharat N, Tornheim JA, Sawant N, Pandya H, Kishore G, Chalwa PK, Karane M, Sayed S, Rodrigues C, Ashavaid TF, Gupta A, Udwadia ZF. A case report on cycloserine induced late onset of psychosis and linezolid induced peripheral neuropathy in an adolescent with drug resistant tuberculosis from the Private sector in Mumbai. Presented at: RePORT India 9th Annual Joint Leadership Meeting: NEXT GEN RePORT, Mumbai, India, February 10-12, 2020.
    Kambli P, Ajbani K, Sadani M, Kazi M, Khillari A, Shetty A, Tornheim JA, Rodrigues C. Targeted next generation sequencing (tNGS) for detection of drug resistant mutations in TB. RePORT India 9th Annual Joint Leadership Meeting: Next Gen RePORT. Mumbai, India: February 10-12, 2020.
  32. Gajjar I, Tornheim JA, Kharat N, Kishore G, Shivakumar SVGY, Chalwa PK, Rodrigues C, Ashavaid TF, Gupta A, Udwadia ZF. Impact of cycloserine treatment on depression among patients treated for multidrug- resistant tuberculosis in the private sector in Mumbai. Presented at: RePORT India 9th Annual Joint Leadership Meeting: NEXT GEN RePORT, Mumbai, India, February 10-12, 2020.
  33. Kharat N, Gajjar I, Tornheim JA, Sawant N, Pandya H, Shivakumar SVGY, Chalwa PK, Rodrigues C, Ashavaid TF, Gupta A, Udwadia ZF. Monitoring household contacts of drug resistant tuberculosis patients for incident infection from the private sector in Mumbai: An ongoing study. Presented at: RePORT India 9th Annual Joint Leadership Meeting: NEXT GEN RePORT, Mumbai, India, February 10-12, 2020.
  34. Gupta A. Overview of RePORT. TBVI. Les Diablarets, Switzerland; January 2020.

Year 2019

  1. Valluri V. Vaccines and immunological markers for TB prevention. Presented at: 50th Annual Union World Conference on Lung Health. Hyderabad, India; October 30–Nov 2, 2019.
  2. Kumar NV. T Cell subsets and cytokines in HIV+ individuals with latent and active tuberculosis. Poster presented at: 50th Annual Union World Conference on Lung Health. Hyderabad, India; October 30–Nov 2, 2019.
  3. Prudhula DK. Defective monocyte signalling pathway in HIV+ individuals with latent tuberculosis infection. Poster presented at: 50th Annual Union World Conference on Lung Health. Hyderabad, India; October 30–Nov 2, 2019.
  4. Mave V. Metabolomics and tuberculosis in Indian context. Presented at RePORT South Africa 2019 Annual Meeting. Johannesburg, South Africa; May 2019.
  5. Alexander M, Bhosale R, Mathad J, Naik S, Divya A, Gupte N, Patil N, Gupta A. Inappropriate postpartum weight loss may predict development of active TB. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  6. Baliashvili D, Gandhi NR, Kim S, Gupta A, Churchyard G, Swindells S, Hesseling A, Hughes M, Shah S for the ACTG 5300/IMPAACT I2003 PHOENIx Feasibility study team. Resistance to Mycobacterium tuberculosis infection among household contacts of MDR TB patients. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  7. Bhosale R, Graham H, Alexander M, Kinikar A, Khwaja S, Patil N, Gupta A, Mathad J, Shivakoti R. Association of latent TB infection in pregnancy with maternal and infant health outcomes in an Indian cohort. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  8. Graham H, Bhosale R, Kinikar A, Alexander M, Patil N, Khwaja, Gupta A, Mathad J, Shivakoti R. Association of HIV infection with perinatal health outcomes among Indian women with and without latent TB infection. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  9. Kim S, Wu X, Hughes M, Mendoza-Ticona A, Churchyard G, Swindells S, Shah NS, Gupta A, Hesseling A for the A5300/I2003 PHOENIx Feasibility Study Team. High prevalence of tuberculosis infection in children living in households of MDR-TB patients. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  10. Kulkarni V, Bhosale R, Jain D, Deshpande P, Alexander M, Patil N, Gupte N, Gupta A, Mathad J. Performance of QuantiFERON-TB Gold In Tube (QFT-GIT) and QuantiFERON- TB Gold Plus (QFT-Plus) for detection of Mycobacterium tuberculosis infection in pregnant women in India Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  11. Mehta S, Murrill M, Suryavanshi N, Bhosale R, Patil N, Gupta A, Mathad J, Shivakoti R, Alexander M. Assessing TB-related knowledge and stigma and associated risk factors among pregnant women in low resource settings of Pune, India. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  12. Naik SN, Chandanwale A, Kadam D, Sambarey PW, Dhumal G, DeLuca A, Jain D, Gupta A, Mave V, Bollinger R. Does treatment of infertile women with probable genital tuberculosis improve fertility outcome? Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  13. Pradhan N, Kagal A, Gupte N, Gaikwad S, Barthwal M, Gupta A, Golub JE, Mave V. Six-week culture conversion predicts tuberculosis treatment outcomes. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  14. Suryavanshi N, Sane M, Gaikwad S, Paradkar M, Mave V, Padmapriyadarsini C, Shivakumar SVBY, Gupta A, Gupte N, Thomas B for CTRIUMPH RePORT India study. Female tuberculosis (TB) patients with stigma are at increased risk of persistent depression: Time to integrate mental health screening in TB care. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 20–November 2, 2019.
  15. Gupte AN, Paradkar M, Selvaraju S, Kumar P, Lokhande R, Kulkarni V, Hanna LE, Thiruvengadam K, Sekar K, Momin A, Shivakumar SVBY, Gupte N, Babu S, Salvi S, Golub J, Checkley W, Bollinger B, Andrade B, Mave V, Padmapriyadarsini C, Gupta A. IL-6, TIMP-2 and TGFβ-2 are associated with respiratory impairment during and following successful treatment of pulmonary tuberculosis. Presented at: RePORT India 2019 Joint Leadership Meeting. Chennai, India; February 4–6, 2019.
  16. Shivakoti R, Padmapriyadarsini C, Hannah LE, Thiruvengadam K, Natarjan S, Karunaianatham R, Mave V, Gupte N, Kulkarni V, Pradhan N, Gupte A, Paradkar M, Shivakumar SVBY, Bharadwaj R, Kagal A, Gaikwad S, Sangle S, Borkowski K, Newman J, Fiehn O, Gupta A for CTRIUMPH RePORT India Study team. Host lipidomic profile associated with adverse tuberculosis treatment outcomes. Presented at: RePORT India 2019 Joint Leadership Meeting. Chennai, India; February 4–6, 2019.
  17. Christopher DJ, Post TB bronchiectasis. Presented at: Nexplore Bronchiectasis Conclave. Candolim, Goa, India; December 14, 2019.
  18. Christopher DJ. Experiences with LTBI screening of healthcare workers in an Indian referral hospital. Presented at: 50th Annual Union World Conference on Lung Health. Hyderabad, India; October 30–November 2, 2019.
  19. Christopher DJ. TB-diabetes link. Presented at: Prof. Dr. M. Viswanathan Oration at the Research Society for the study of Diabetes in India, Annual Conference. Dindigul, Tamil Nadu, India; August 10, 2019.
  20. David DS, Irodi A, Chacko BR, RV Leena, Christopher DJ, Gupta R. Effectiveness of digital chest radiograph as a Triage tool among patients with clinical suspicion of pulmonary tuberculosis. Annual conference of the society of chest imaging and interventions. SCII-CON. April 2019.
  21. Christopher DJ, Kuruvilla L, Sarangi PK, Irodi A, Chacko B, Leena RV, Shankar D, Thangakunam B. Comparison of chest radiographic pattern in diabetic and non-diabetic patients with pulmonary tuberculosis. Presented at: 29th ERS International Congress, IFEMA. Madrid, Spain; September 28–October 2, 2019.
  22. Christopher DJ, Deva J, Thangakunam B, Mathew BS, Winston B. Anti-tubercular drug concentrations in pulmonary tuberculosis patients—Diabetics vs non-diabetics. Presented at: 29th ERS International Congress, IFEMA. Madrid, Spain; September 28–October 2, 2019.
  23. Christopher DJ. Experiences with LTBI screening of healthcare workers in an Indian referral hospital. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India; October 30–Nov 2, 2019.
  24. Christopher DJ. Chest radiologic pattern in Diabetic patients with Pulmonary Tuberculosis (PTB). Abstract presented at: ERS International Congress 2019, September 2019.
  25. Christopher DJ . Anti-tubercular drug concentrations in Pulmonary Tuberculosis patients – Diabetic vs Non-Diabetic groups. Abstract presented at: ERS International Congress 2019, September 2019; DOI: 10.1183/13993003.congress-2019.PA2999
  26. Christopher DJ, Christopher SA, Balamugesh. T, Hephzibah J, David T, Sathyendra S, Abraham OC, Ramya I, Mathuram A. Role of PET CT scans in tuberculous meningitis. Presented at: RePORT India 2019 Joint Leadership Meeting. Chennai, Tamil Nadu, India; February 4–6, 2019.
  27. Christopher DJ, Deva J, Thangakunam B, Mathew BS, Winston B. Plasma drug concentrations of isoniazid and rifampicin in pulmonary tuberculosis patients with diabetes. Presented at: RePORT India 2019 Joint Leadership Meeting. Chennai, Tamil Nadu, India; February 4–6, 2019.
  28. Christopher DJ, Shankar D, Hemanth Kumar AK, Thangakunam B, Kannan T, Ramachandran G. Pharmacokinetics of rifampicin, isoniazid and pyrazinamide during daily and intermittent dosing. Presented at: RePORT India 2019 Joint Leadership Meeting. Chennai, Tamil Nadu, India; February 4–6, 2019.
  29. Christopher DJ, Arjun AC, Balamugesh T, David T, Sathyendra S, Ramya I, Abraham OC, Mathuram A, Ramakrishnan L. Predictors of mortality in a TB meningitis cohort. Presented at: RePORT India 2019 Joint Leadership Meeting. Chennai, Tamil Nadu, India; February 4–6, 2019.
  30. Christopher DJ, Arjun AC, Balamugesh T, Shankar D. Respiratory and non-respiratory comorbidities in tuberculosis. Presented at: RePORT India 2019 Joint Leadership Meeting. Chennai, Tamil Nadu, India; February 4–6, 2019.
  31. Hochberg, NS. Tuberculosis: The fundamentals and the sea changes. Presented at: MPH Course: Global Health Priorities & Approaches. Tufts University School of Medicine. Boston, MA, USA; 2019.
  32. Hochberg, NS. Malnutrition and tuberculosis. World TB Day, National Regional Conference, Albany, NY, USA; 2019.
  33. Hochberg, NS. Malnutrition and tuberculosis. Providence/Boston CFAR TB/HIV Scientific Working Group TB Interest Group Round Table. Boston, MA, USA; 2019
  34. Hochberg, NS. The skinny on tuberculosis: Why malnutrition matters. Infectious Diseases Grand Rounds. Presented at: Boston Medical Center. Boston MA, USA; 2019.
  35. Abilasha N, Bharath B, Priyanga J, Senbagavalli P, Prakash B, Vinod K, Subitha L, Roy G, Salgame P, Muthuraj M, Roy G, Sarkar S, Hochberg NS, Noyal J. Effect of diabetes prevalence on circulating components of blood, disease severity and drug susceptibility in patients with pulmonary tuberculosis. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 30–November 2, 2019.
  36. Kornfeld H. TB and diabetes from bench to bedside and back. Presented at: 2nd International Symposium on Frontiers in Biomedical Science of Infection Control Convergence Medical Research Center, MMRC. Chungnam National University. Daejeon, Korea; October 15, 2019.
  37. Shruthi BS, Sivakumar S, Arutselvi D, Kumar NP, Babu S, Menon PA, Natarajan M, Sathyavani K, Kornfeld H, Viswanathan V. Association of diabetes mellitus with INH monoresistance. Presented at: RePORT India 2019 Joint Leadership Meeting. Chennai, India; February 4–6, 2019.
  38. Kumar NP, Moideen K, Sivakumar S, Menon P, Viswanathan V, Kornfeld H, Babu S. Altered circulating levels of eicosanoids in tuberculosis-diabetes co-morbidity and reversal upon standard tuberculosis treatment. Presented at: Keystone Symposia -Tuberculosis: Mechanisms, Pathogenesis and Treatment. Banff, Alberta, Canada; January 17–21, 2019.
  39. Chawla PK, Naik P, Lokhande R, Dherai AJ, Udwadia ZF, Mahashur AA, Pinto L, Mullerpattan J, Sunavala A, Soman R, Rodrigues C, Gupta A, Tornheim JA, Martinson N, Variava E, Wiesner L, Joubert A, Ashavaid TF. Therapeutic drug monitoring of moxifloxacin in Indian MDR-TB patients. Presented at: Association of Clinical Biochemists of India. 15th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) Congress. Jaipur, India; November 17–20, 2019.
  40. Tornheim JA, Gajjar I, Shivakumar SVBY, Gupte AN, Kishore G, Karane M, Rodrigues C, Gupta A, Udwadia ZF. Increased moxifloxacin dosing among MDR-TB patients with low-level resistance to moxifloxacin did not improve treatment outcomes in a tertiary care centre in Mumbai, India. Presented at: 50th Union World Conference on Lung Health. Hyderabad, India. October 30-November 2, 2019.
  41. Chawla PK, Lokhande RV, Naik PR, Dherai AJ, Udwadia ZF, Mahashur AA, Pinto L, Soman R, Rodrigues C, Gupta A, Tornheim JA, Martinson N, Variava E, Wiesner L, Joubert A, Ashavaid TF. Therapeutic drug monitoring of clofazimine in Indian MDR-TB patients. Presented at: MSACL 2019 EU. Salzburg, Austria; September 22–26, 2019.
  42. Chawla PK, Lokhande RV, Naik PR, Dherai AJ, Udwadia ZF, Mahashur AA, Soman R, Rodrigues C, Gupta A, Tornheim JA, Martinson N, Variava E, Wiesner L, Joubert A, Ashavaid TF. Determination of plasma clofazimine levels by liquid chromatography-mass spectrometry. Presented at: 32nd Annual Research Day, P.D. Hinduja Hospital and MRC. Mumbai, India; March 2, 2019 & RePORT India 2019 Joint Leadership Meeting: Biomarkers and Beyond. Chennai, India; February 4–6, 2019.
  43. Chawla PK, Lokhande RV, Naik PR, Dherai AJ, Udwadia ZF, Mahashur AA, Soman R, Rodrigues C, Gupta A, Tornheim JA, Ashavaid TF. Determination of serum linezolid levels by HPLC. Presented at: 32nd Annual Research Day, P.D. Hinduja Hospital and MRC. Mumbai, India; March 2, 2019 (Awarded 2nd Prize for Best Laboratory paper) & RePORT India 2019 Joint Leadership Meeting: Biomarkers and Beyond. Chennai, India; February 4–6, 2019.
  44. Tornheim JA, Udwadia ZF, Porwal S, Kishore G, Gajjar I, Karane M, Shivakumar SVBY, Rodrigues C, Gupta A. Impact of standard or increased moxifloxacin dose among MDR-TB patients in Mumbai with low-level resistance. Presented at: RePORT India 2019 Joint Leadership Meeting: Biomarkers and Beyond. Chennai, India; February 4–6, 2019.
  45. Gajjar IN, Tornheim JA, Udwadia ZF, Kishore G, Karane M, Sayed S, Chawla P, Rodrigues C, Ashavaid T, Shivakumar SVBY, Gupta A. Quality of life among MDR-TB patients from the public sector in Mumbai. Presented at: RePORT India 2019 Joint Leadership Meeting: Biomarkers and Beyond. Chennai, India; February 4–6, 2019.
  46. Shivakumar SVBY, Tornheim JA, Gajjar I, Porwal S, Kishore G, Karane M, Chawla P, Rodrigues C, Ashavaid T, Gupta A, Udwadia ZF. Mental health and TB: High prevalence of depression among drug-resistant TB patients not associated with cycloserine. Presented at: RePORT India 2019 Joint Leadership Meeting: Biomarkers and Beyond. Chennai, India; February 4–6, 2019.
  47. Kambli P, Tornheim JA, Soundararajan L, Priyadarshini S, Gupta R, Ramprasad VL, Gupta A, Rodrigues C. Whole genome sequencing of Mycobacterium tuberculosis directly from clinical samples accurately identifies drug resistance. Presented at: RePORT India 2019 Joint Leadership Meeting: Biomarkers and Beyond. Chennai, India; February 4–6, 2019.
  48. Ajbani K, Kazi M, Naik S, Soman R, Shetty A, Rodrigues C. Simultaneous rapid detection of tubercular meningitis and drug susceptibility testing using pyrosequencing on uncultured cerebrospinal fluid samples. Presented at: RePORT India 2019 Joint Leadership Meeting: Biomarkers and Beyond. Chennai, India; February 4–6, 2019.
  49. Nambiar R, Tornheim JA, Diricks M, Katrien DB, Sadani M, Shetty A, Rodrigues C. Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care center in Mumbai, India, by whole genome sequencing. Presented at: RePORT India 2019 Joint Leadership Meeting: Biomarkers and Beyond. Chennai, India; February 4–6, 2019.

Year 2018

  1. Devalraju KP, Neela VSK, Chaudhury A, Vankayalapati R, Valluri VL. NK cells and memory-like NK cells as immunological markers of protection against latent TB conversion in household contacts of TB patients. Abstract presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  2. Neela VSK, Devalraju KP, Sumnalatha G, Chowdary A, Ansari MS, Vankayalapati R, Valluri VL. CD14+ CD16+ cells as immunological marker for protection in household contacts with latent tuberculosis infection. Abstract presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  3. Gupta A. Panelist. Leveraging collective impact to promote India’s development: The role of the Indian diaspora in the fight against tuberculosis. The Role of the Indian Diaspora in the Fight Against Tuberculosis. Georgetown University. Washington, DC, USA; October 2, 2018.
  4. Kinikar A. Update on RICC pediatric transcriptomic study—India component. RePORT International Annual Meeting. Szouchou, China; September 12–14, 2018.
  5. DeLuca A, Thomas B, Suryavanshi N, Jain D, Paradkar M, Gupte A, Padmapriyadarsini C, Gupta A for the CTRIUMPH RePORT India Study Team. Alcohol use disorder, drinking patterns, and tuberculosis treatment failure in Indian patients. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands. October 24–27, 2018.
  6. Gupte A, Kumar P, Kulkarni V, Bharadwaj R, Andrade B, Mave V, Padmapriyadarsini C, Gupta A. Interleukin-6, interleukin-13 and interferon-γ as potential biomarkers for treatment failure in pulmonary tuberculosis. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands; October 24–27, 2018.
  7. Gupte N, Gupte A, Sivaramakrishnan GN, Pradhan N, Shivakumar SVBY, Gupta A, Mave V, Padmapriyadarsini C for the C-TRIUMPH RePORT India team. Time to culture conversion, identifying independent modifiable risk factors in Indian patients. Presented at 49th Union World Conference on Lung Health. The Hague, The Netherlands; October 24–27, 2018.
  8. Thomas B, Kannan T, Rani V, Gupte N, Gupta A, Deluca A, Suryavanshi N, Kohli R, Padmapriyadarsini C for the C-TRIUMPH RePORT India Study Team. Does smoking have an impact on TB treatment outcomes? A prospective cohort study from India. Session: Tobacco Use in Various Populations: Implications for Policy and Practice. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands; October 24–27, 2018.
  9. Ramachandran G, Padmapriyadarsini C, Gaikwad S, Kumar AKH, Thiruvengadam K, Gupte N, Paradkar M, Dhanasekaran K, Sivaramakrishnan GN, Kagal A, Thomas B, Pradhan N, Kadam D, Hanna LE, Balasubramanian U, Kulkarni V, Murali L, Golub J, Gupte A, Shivakumar SVBY, Swaminathan S, Dooley KE, Gupta A, Mave V for the C-TRIUMPH Study Team. Sub-therapeutic rifampicin concentration among thrice weekly treated PTB patients with unfavorable treatment outcomes. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands; October 24–27, 2018.
  10. Gupte A, Paradkar M, Selvaraju S, Shivakumar SVBY, Kohli R, Momin A, Gaikwad S, Jain D, Raskar S, Suryavanshi N, Thiruvengadam K, Sekar K, Kumar B, Yashoda R, Lokhande R, Gupte N, Golub J, Padmapriyadarsini C, Mave V, Gupta A. Hyperglycemia and impairment in treated pulmonary tuberculosis. RePORT International Young Investigator Abstract Presentation at: RePORT International 2018 Annual Meeting. Suzhou, China; September 12–14, 2018.
  11. Paradkar M, Padmapriyadarsini C, Shivakumar SVBY, Jain D, Thiruvengadam K, Gupte A, Thomas B, Kinikar A, Bharadwaj R, Gaikwad S, Lokhande R, Dolla CK, Selvaraju S, Murali L, Rajagopal S, Kulkarni V, Pradhan N, Hannah LE, Pattabiraman S, Kohli R, Nayagam R, Suryavanshi N, Cox S, Gupte N, Mave V, Gupta A for the C-TRIUMPH Study Team. Incidence of Mycobacterium tuberculosis infection among household contacts of adult pulmonary Tuberculosis cases in India. RePORT International Young Investigator Abstract Presentation at: RePORT International 2018 Annual Meeting. Suzhou, China; September 12–14, 2018.
  12. Dolla CK, Paradkar M, Gupte A, Thiruvenkadam K, Gupte N, Kulkarni V, Balasubramanian U, Hannah LE, Dhanasekaran K, Bharadwaj R, Shivakumar SVBY, Gaikwad S, Meshram S, Kohli R, Lokhande R, Thomas B, Kinikar A, Swaminathan S, Mave V, Gupta A, Padmapriyadarsini C. TB infection among household contacts: Preventive therapy for all? Presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  13. Dhanasekaran K, Padmapriyadarsini C, Paradkar M, Marinaik SB, Gupte A, Dolla CK, Joseph B, Subramanyam B, Sivaramakrishnan GN, Thiruvengadam K, Gupte N, Rajagopal S, Pradhan N, Selvaraju S, Kulkarni V, Hannah LE, Nayakam R, Suryavanshi N, Shivakumar SVBY, Mave V, Thomas B, Bharadwaj R, Gaikwad S, Meshram S, Lokhande R, Kinikar A, Daware R, Murali L, Swaminathan S, Gupta A for the C-TRIUMPH Study Team. Risk factors associated with unfavorable outcomes in a cohort of pulmonary TB patients. Presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  14. Paradkar M, Dhanasekaran K, Kinikar A, Kulkarni R, Bharadwaj R, Gaikwad S, Lokhande R, Meshram S, Dolla CK, Selvaraju S, Murali L, Thiruvengadam K, Jain D, Rajagopal S, Kulkarni V, Pradhan N, Shalini J, Kohli R, Nayagam R, Shivakumar SVBY, Suryavanshi N, Gupte A, Gupte N, Padmapriyadarsini C, Mave V, Gupta A for the C-TRIUMPH Study Team. Incidence of Mycobacterium tuberculosis infection among household contacts of adult pulmonary tuberculosis cases in India. Presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  15. Selvaraju S, Thiruvenkadam K, Paradkar M, Marinaik SB, Bharadwaj R, Rajagopalan S, Gaikwad S, Pattabiraman S, Kinikar A, Sivaramakrishnan GN, Meshram S, Hanna LE, Lokhande R, Dhanasekaran K, Gupte A, John S, Gupte N, Thomas B, Kulkarni V, Ayyanu S, Kohli R, Shivakumar SVBY, Swaminathan S, Mave V, Gupta A, Chandrasekaran for the CTRIUMPh Study Team. Incidence of Mycobacterium tuberculosis infection among household contacts of adult pulmonary tuberculosis cases in India. Presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  16. Mave V, Padmapriyadarsini C, Paradkar M, Gupte A, Pradhan N, Sivaramakrishnan GN, Thiruvenkadam K, Shivakumar SVBY, Kulkarni V, Dhanasekaran K, Subramanyam B, Selvaraju S, Murali L, Bharadwaj R, Gaikwad S, Meshram S, Kinikar A, Hanna LE, Swaminathan S, Gupte N, Gupta A. Infection free “resistors” among household contacts of culture-confirmed adult pulmonary TB cases. Presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  17. Tornheim JA, Paradkar M, Valvi C, Gupte N, Madugundu A, Kulkarni V, Sreenivasamurthy S, Raja R, Pradhan N, Shivakumar SVBY, Kohli R, Gupte A, Padmapriyadarsini C, Mave V, Pandey A, Gupta A. Gene expression profiles of pediatric tuberculosis patients and exposed controls from India. Presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  18. Dhumal G. Poor understanding of TB infection among at-risk tuberculin skin-test positive household contacts of pulmonary TB cases in Pune, India. Presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  19. Mathad J, Alexander A, Bhosale R, Naik S, Suryavanshi N, Mave V, Deshpande P, Balasubramanian U, Kulkarni V, Kumar P, Babu S, Gupte N, Nevrekar N, Patil S, Chandanwale A, Gupta A. The effect of HIV on the immune response to Mycobacterium tuberculosis in pregnant women from Pune, India. Presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  20. Tornheim JA, Madugundu AK, Pradhan N, Bharadwaj R, Mave V, Golub J, Pandey A, Gupta A. Drug susceptibility of rifampin-resistant tuberculosis using whole genome sequencing to identify genes of interest in Pune, India. Presented at: 5thGlobal Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  21. Christopher DJ. Is India’s endeavor to end TB by 2025 achievable? Presented at: 36th AP Tuberculosis & Chest Diseases Conference. Madanapally, Andhra Pradesh, India; November 10–11, 2018.
  22. Christopher DJ. Addressing diagnostic challenges for TB meningitis—From clinical staging to PET Scanning. Presented at: 49th Union World Conference on Lung Health. The Hague, The Netherlands; October 24–27, 2018.
  23. Christopher DJ. Is India’s endeavor to end TB by 2025 achievable? How can RePORT align with this? Presented at: RePORT International 2018 Annual Meeting. Suzhou, China; September 12–14, 2018.
  24. Christopher DJ. Determination of efficacy of expert PCR ultra and transcriptional signatures in the diagnosis of pleural tuberculosis. Presented at: RePORT International 2018 Annual Meeting. Suzhou, China; September 12–14, 2018.
  25. Christopher DJ. Healthcare personnel TB—Fact of life in high burden countries. Presented at: RePORT International 2018 Annual Meeting. Suzhou, China; September 12–14, 2018.
  26. Christopher DJ. Point of care diagnostics and need for triage test in a high prevalence setting. Presented at: Investigators Meeting: Understanding the Resources and Gaps in DAIDS funded TB Research. NIAID Conference Center. Rockville, MD, USA; July 2–3, 2018.
  27. Christopher DJ. Battling the white plague (TB) in our campuses. Presented at: The Quality Circle, Christian Medical College. Vellore, India; April 14, 2018.
  28. Christopher DJ. Targeted LTBI testing. Presented at: LTBI Knowledge Seminar. Hyderabad, India; January 11, 2018.
  29. Christopher DJ, Thangakunam B, Shankar D, Samuvel S, Oliver A, Deepak A. Empirical treatment of smear negative ‘supposedly’ pulmonary tuberculosis patients—Is it right? Presented at: RePORT India 2018 Joint Leadership Meeting. Delhi, India; February 15–17, 2018.
  30. Christopher DJ, Thangakunam B, Samuvel S, Deepak A, Shankar D, Mathuram A, David T, Sathyendra S, Abraham OC, Ramya I, Ramakrishnan L. Comparison of profile of Indian patients with tubercular meningitis in the CMC, Vellore, cohort with other cohorts. Presented at: RePORT India 2018 Joint Leadership Meeting. Delhi, India; February 15–17, 2018.
  31. Christopher DJ, Shankar D, Micheal JS, Thangakunam B, Ramakrishnan L. Factors affecting time to sputum smear and culture conversion in adults with pulmonary tuberculosis: A prospective cohort study from CMC RePORT data. Presented at: RePORT India 2018 Joint Leadership Meeting. Delhi, India; February 15–17, 2018.
  32. Chua A, Mowry WB, Sahu S, Roy G, Ellner JJ, Horsburgh Jr CR, Pleskunas J, Sarkar S, Hochberg NS, Reddy D. Does the form of tobacco product used by smokers influence pulmonary tuberculosis severity? Presented at: ATS 2018. San Diego, CA, USA; May 18–23, 2018.
  33. Abilasha N, Bharath B, Priyanga J, Senbagavalli P, Prakash B, Vinod K, Subitha L, Roy G, Salgame P, Muthuraj M, Roy G, Sarkar S, Hochberg NS, Noyal J. Effect of diabetes prevalence on circulating components of blood, disease severity and drug susceptibility in patients with pulmonary tuberculosis. Presented at: RePORT India 2018 Joint Leadership Meeting. Chennai, India; February 14-16, 2018.
  34. Schenk NM, Sahu S, Roy G, Ellner JJ, Horsburgh Jr CR, Pleskunas J, Sarkar S, Hochberg NS, Reddy D. Influence of type of tobacco product on chest X-ray findings in pulmonary tuberculosis patients in India. Presented at: RePORT India 2018 Joint Leadership Meeting. Chennai, India; February 14-16, 2018.
  35. Hoyt K, White L, Sarkar S, Pleskunas J, Zhou T, Noyal J, Muthuraj M, Vinod K, Roy G, Ellner JJ, Horsburgh Jr CR, Hochberg NS. Effect of malnutrition on tuberculosis mycobacterial burden and chest radiographic findings. Presented at: RePORT India 2018 Joint Leadership Meeting. Chennai, India; February 14-16, 2018.
  36. Reddy D. Wood fuel usage is associated with a higher leukocyte count in pulmonary tuberculosis patients. Presented at: RePORT India 2018 Joint Leadership Meeting. Chennai, India; February 14-16, 2018.
  37. Forsyth M. Alcohol use and clinical presentation of tuberculosis at time of diagnosis in Puducherry and Tamil Nadu, India. Presented at: RePORT India 2018 Joint Leadership Meeting. Chennai, India; February 14-16, 2018.
  38. Kornfeld H. AMP kinase activation as host-directed therapy for tuberculosis. 49th Union World Conference on Lung Health. The Hague, Netherlands; October 23–26, 2018.
  39. Kumar NP, Moideen K, Sivakumar S, Menon P, Viswanathan V, Kornfeld H, Babu S. Effect of standard tuberculosis treatment on circulating levels of pro-inflammatory cytokines in tuberculosis-diabetes comorbidity. Presented at Keystone Symposia -Tuberculosis: Translating Scientific Findings for Clinical and Public Health Impact. Whistler, BC, Canada; April 15–19, 2018.
  40. Kornfeld H. TB and diabetes from bench to bedside and back. Presented at: American Thoracic Society International Conference ATS San Diego, CA, USA; March 22, 2018.
  41. Kornfeld H. Diabetic immunopathy and TB. Presented at: TB Conference. The Union-North American Region, Chicago, IL, USA; March 3, 2018.
  42. Kornfeld H. TB and diabetes from bench to bedside and back. Presented at: Division of Infectious Disease, Boston University School of Medicine. Boston, MA, USA; January 25, 2018.
  43. Kornfeld H. TB and diabetes from bench to bedside and back. Presented at: Division of Endocrinology, University of Massachusetts School of Medicine. Worcester, MA, USA; January 9, 2018.
  44. Kumar NP, Moideen K, Sivakumar S, Menon P, Viswanathan V, Kornfeld H, Babu S. Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity Presented at: IMMUNOCON 2018 45th Annual Meeting of Indian Immunology Society. TSHTI, Faridabad, India; November 1–3, 2018.
  45. Kumar NP, Moideen K, Sivakumar S, Menon P, Viswanathan V, Kornfeld H, Babu S. Effect of anti-tuberculosis treatment on the systemic levels of matrix metalloproteinases and tissue inhibitors of MMP in tuberculosis–diabetes comorbidity. Presented at: 5th Global Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  46. Moideen K, Kumar NP, Bethunaickan R, Sivakumar S, Menon PA, Viswanathan V, Shruthi BS, Kornfeld H, Babu S. Altered systemic levels of neutrophil and mast cell granular proteins in tuberculosis-diabetes comorbidity and changes following treatment. Presented at: 5th Global Forum on TB Vaccines. New Delhi, India; February 20–23, 2018.
  47. Shruthi BS. Impact of metformin use on TB severity in diabetes. Presented at: RePORT India 2018 Joint Leadership Meeting: Catalyzing Discoveries toward TB Elimination. Delhi, India; February 15, 2018.
  48. Moideen K. Effect of anti-tuberculosis treatment on the systemic levels of matrix metalloproteinases and tissue inhibitors of MMP in tuberculosis–diabetes comorbidity. Presented at: RePORT India 2018 Joint Leadership Meeting: Catalyzing Discoveries toward TB Elimination. Delhi, India; February 15, 2018.
  49. Kumar NP. Effect of standard tuberculosis treatment on circulating levels of monocyte activation markers and RAGE ligands in tuberculosis–diabetes comorbidity. Presented at: RePORT India 2018 Joint Leadership Meeting: Catalyzing Discoveries toward TB Elimination. Delhi, India; February 15, 2018.
  50. Chawla PK, Lokhande RV, Naik PR, Singh S, Dherai AJ, Udwadia ZF, Pinto L, Soman R, Rodrigues C, Patel J, Ashavaid TF. Implications of acetylator genotype on plasma rifampicin and isoniazid levels in TB patients. Presented at: 45th National Conference of Association of Clinical Biochemists of India (ACBICON 2018). Goa, India; October 25–27, 2018.
  51. Chawla PK, Lokhande RV, Naik PR, Dherai AJ, Udwadia ZF, Rodrigues CR, Mahashur AA, Soman R, Patel J, Ashavaid TF. Implication of acetylator genotype of plasma rifampcin and isoniazid. Oral Presentation at: 31st Annual Research Day. (Awarded 1st Prize for Best Laboratory paper) P.D. Hinduja Hospital and MRC. Mumbai, India; March 3, 2018.
  52. Tornheim J, Ganatra S, Deluca A, Banka R, Rodrigues C, Gupta A, Udwadia Z. Linezolid experience among MDRTB patients in Mumbai. Presented at: RePORT India 2018 Joint Leadership Meeting: Catalyzing Discoveries toward TB Elimination. Delhi, India; February 15, 2018.
  53. Gupta A, Rodrigues C, Christopher DJ, Kornfeld H, Ellner J, Mave V, Devalraju KP. RePORT India Symposium: Biomarkers, diagnostics, and comorbidities. 49th Union World Conference on Lung Health. The Hague, The Netherlands; October 25, 2018.
  54. Gupta A. RePORT India overview. Presented at: CFAR RePORT International Meeting. Rockville, MD; July 2, 2018.
  55. Gupta A. Keynote Address: Global health diplomacy: Why it really matters! (RePORT India described) AAAS Science & Technology. Washington, DC; May 31, 2018.
  56. Gupta, A. Keynote Address: The challenge of eliminating TB in India. (RePORT India described) University of Washington TB Symposium. Seattle, WA; May 18, 2018.

Year 2017

  1. Padmapriyadarsini C. TB research in India. Presented at: 1st BRICS TB Research Network Meeting. Rio de Janeiro, Brazil; September 14–15, 2017.
  2. Mave V. Diabetes and drug levels: Rifampin + other drugs. Presented at: RePORT International 2017 Annual Meeting. Rio de Janeiro, Brazil; September 2017.
  3. Padmapriyadarsini C. Ongoing research and research priorities for India on LTBI. Presented at: WHO Global TB Programme Technical Consultation Meeting on Programmatic Management of Latent Tuberculosis Infection (LTBI). Seoul, Republic of Korea; August 31–September 1, 2017.
  4. Belgaumkar V. Barriers to contact screening and isoniazid preventive therapy among pediatric contacts of adults with smear-positive tuberculosis. Presented at: 48th Union World Conference on Lung Health. Guadalajara, Mexico; October 13, 2017.
  5. DeLuca A, Dhumal G, Paradkar M, Suryavanshi N, Mave V, Kohli R, Shivakumar SVBY, Gupta A. Lack of TB knowledge among TST-positive household contacts of pulmonary cases: A missed opportunity. Presented at: 48th Union World Conference on Lung Health. Guadalajara, Mexico; October 13, 2017.
  6. Tornheim J, Paradkar M, Valvi C, Gupte N, Madugundu A, Kulkarni V, Sreenivasamurthy S, Raja R, Pradhan N, Shivakumar SVBY, Kohli R, Padmapriyadarsini C, Pandey A, Mave V, Gupta A. Gene expression profiles of pediatric tuberculosis patients and exposed controls from India. Presented at: RePORT International 2017 Annual Meeting. Rio de Janeiro, Brazil; September 13; 2017.
  7. Gupte A, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub J. Trends in glycated hemoglobin levels and implications for diabetes screening among pulmonary tuberculosis cases undergoing treatment in India. RePORT International 2017 Annual Meeting. Rio de Janeiro, Brazil; September 13; 2017.
  8. Shivakumar SVBY, Padmapriyadarsini C, Paradkar M, Danasekaran K, Kumar AMV, Ramachandran G, Thomas B, Suryavanshi N, Kohli R, Thiruvengadam K, Gupte N, Kulkarni V, Hannah LE, Gomathy NS, Pradhan N, Dolla CK, Gupte A, DeLuca A, Meshram S, Kagal AD, Golub J, Selvaraj K, Murali L, Swaminathan S, Mave V, Gupta A. High burden of dysglycemia among contacts of tuberculosis patients in India: Is it time to screen them all? RePORT International 2017 Annual Meeting. Rio de Janeiro, Brazil; September 13; 2017.
  9. Tornheim J, Paradkar M. C-TRIUMPH pediatric biomarker substudy. Invited Presentation. Session: The Future of MDR-TB Treatment in Children. 2017 IMPAACT Network Annual Meeting. Washington, DC, USA; May 30, 2017.
  10. Mathad J, Alexander M, Bhosale R, Naik S, Shivakoti R, Mave V, Suryavanshi N, Gupte N, Kulkarni V, Pradhan N, Patil N, Gupta A. Impact of immune changes of pregnancy and HIV infection on tuberculosis. Presented at: RePORT India 2017 Joint Leadership Meeting. Hyderabad, India; February 3, 2017.
  11. Gupte A, Meshram S, Selvaraju S, Gupte N, Shivakumar SVBY, Paradkar M, Kohli R, Thiruvengadam K, Suryavanshi N, Padmapriyadarsini C, Mave V, Swaminathan S, Gupta A, Golub J, Checkley W. Host factors associated with poor respiratory health-related quality of life in pulmonary tuberculosis. Presented at: RePORT India 2017 Joint Leadership Meeting. Hyderabad, India; February 3, 2017.
  12. Padmapriyadarsini C, Thiruvengadam K, Gupte N, Luck EH, Mave V, Gupte A, Gupta A, Swaminathan S. Household contact tracing of adult pulmonary TB patients in India: Prevalence of TB disease and infection. Presented at: RePORT India 2017 Joint Leadership Meeting. Hyderabad, India; February 3, 2017.
  13. Paradkar M, Kavitha D, Shivakumar SVBY, Khadse S, Khwaja S, Hari K, Rani N, Thiruvengadam K, Gupte N, Raskar S, Jain D, Suryavanshi S, Kohli R, Kulkarni V, Pradhan N, Sathyamurthi B, Tornheim J, Gupte A, DeLuca A, Mave V, Padmapriyadarsini C, Gupta A for the C-TRIUMPH Study Team. Descriptive baseline characteristics, treatment outcomes, and biorepository of pediatric TB cases in C-TRIUMPH–RePORT India prospective cohort. Presented at: RePORT India 2017 Joint Leadership Meeting. Hyderabad, India; February 3, 2017.
  14. John S, DeLuca A, Paradkar M, Nayagam R, Shivakumar SVBY, Gupte A, Gupte N, Thomas B, Suryavanshi N, Kolhi R, Golub J, Kulkarni V, Pradhan N, Mave V, Padmapriyadarsini C, Gupta A. Alcohol use among adult pulmonary and extra-pulmonary TB cases in the C-TRIUMPH India cohort. Presented at: RePORT India 2017 Joint Leadership Meeting. Hyderabad, India; February 3, 2017.
  15. Christopher DJ. LTBI screening in high TB prevalence setting. Presented at: Qiagen Knowledge Seminar. Bangalore, India; November 2, 2017.
  16. Christopher DJ. LTBI Screening: A clinician’s perspective. Presented at: CME organized by Qiagen. New Delhi; India. April 5, 2017.
  17. Christopher DJ. LTBI: To screen or not to screen. Presented at: Three T’s of TB Prevention: Test, Treat, and Track Symposium. Asia Pacific Regional Conference; International Union against Tuberculosis. Tokyo, Japan; March 23, 2017.
  18. Christopher DJ, Dinakaran S, Gupta R, Prince J, Isaac B, Thangakunam B. Large thoracoscopic pleural biopsy improves yield of Xpert MTB/RIF for diagnosis of pleural tuberculosis. Presented at: BRONCOCON, CMC Vellore. Vellore, India; March 2–4, 2017.
  19. Hochberg NS. Indo-U.S. TB cohort: Study design and preliminary results. Presented at: TB Research Unit (TBRU) Investigators Meeting. Boston, MA, USA; September 2017.
  20. Hochberg NS. Updates in tuberculosis: The era of sea changes. Medicine Grand Rounds. Presented at: Carney Hospital. Dorchester, MA. USA; March 2017.
  21. Hochberg NS. Malnutrition and TB in India: Intersection and implications. Presented at: Northeastern World TB Day Symposium. Boston, MA, USA. March 6–7, 2017.
  22. Johnson WE, Knudsen S, Hochberg N, Joseph N, Roy G, Sarkar S, Ellner J, Salgame P. Optimizing parsimonious gene signatures defining the spectrum of tuberculosis infection. Presented at: 48th Union World Conference on Lung Health. Hyderabad, India; October 2017.
  23. Johnson WE. Parsimonious gene signatures for TB outcomes. Presented at: JIPMER. Pondicherry, India; November 2017.
  24. Johnson WE. Addressing unwanted heterogeneity in genomic data: Applications in RNA-sequencing and prediction. Presented at: Department of Statistics, University of Connecticut. Storrs, CT, USA; November 2017.
  25. Kornfeld H. Clinical and immunological findings from the Effect of Diabetes on TB (EDOTS) study in India. Presented at: 48th Union World Conference on Lung Health. Guadalajara, Mexico; October 11–14, 2017.
  26. Kornfeld H. Impact of diabetes and hyperlipidemia on host defense. Presented at: 48th Union World Conference on Lung Health. Guadalajara, Mexico; October 11–14, 2017.
  27. Kornfeld H. Sugar, fat, and consumption. Presented at: Infectious Diseases Grand Rounds, Perelman School of Medicine, University of Pennsylvania. Philadelphia, PA, USA; September 28, 2017.
  28. Kornfeld H. Intersection between TB & diabetes. Presented at: New England TB Clinicians’ Conference, University of Massachusetts Medical School. Worcester, MA, USA; May 11, 2017.
  29. Kornfeld H. Diabetic immunopathy and TB. Presented at: Rollins School of Public Health, Emory University. Atlanta, GA, USA; April 20, 2017.
  30. Kornfeld H. Diabetic immunopathy & TB. Presented at: Meakins-Christie Laboratories, McGill University. Montreal, Canada; April 10, 2017.
  31. Kornfeld H. Diabetic immunopathy and TB. Presented at: National TB Conference. Atlanta, GA, USA; 21 April 2017.
  32.  Chawla PK, Lokhande RV, Naik PR, Dherai AJ, Udwadia ZF, Mahashur AA, Soman R, Patel J, Ashavaid TF. Therapeutic drug monitoring of rifampicin and isoniazid and implications of acetylator genotype on plasma levels. Presented at: 15th International Congress on Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). Kyoto, Japan; September 27, 2017.
  33. Tornheim J, DeLuca A, Ganatra S, Radhika B, Gupta A, Udwadia Z. It simply won’t work here: Few eligible for the newly recommended short course MDR-TB regimen in a Mumbai private clinic. Presented at: American Thoracic Society 2017 International Conference. Washington, DC, USA; May 21, 2017.
  34. Tornheim JA, Ganatra S, DeLuca A, Banka R, Gupta A, Udwadia ZF. Impact of drug susceptibility testing on drug choice in a tuberculosis cohort with high rates of drug resistance from the private sector in Mumbai. Presented at: RePORT India 2016 Joint Leadership Meeting. Hyderabad, India; February 3, 2017.

Archives

2014, 2015, 2016

Year 2016
  1. Devalraju KP. Identify potential biomarkers for development of latent tuberculosis infection (LTBI) by longitudinal follow-up of HHCs of TB patients. Presented at: Presented at: RePORT International 2016 Annual Meeting. Durban, South Africa; July 14–15, 2016.
  2. Cheekatla SS, Tripathi D, Venkatasubramanian S, Nathella PK, Paidipally P, Ishibashi M, Welch E, Tvinnereim AR, Mitsuo I, Babu S, Kornfeld H, Vankayalapati R. NK-DC crosstalk in diabetes enhances Il-6 mediated inflammation during tuberculosis infection. Poster presented at: Keystone Symposium on Tuberculosis Co-Morbidities and Immunopathogenesis (B6). Keystone, CO, USA; February 28–March 3, 2016.
  3. Mave V. Participant recruitment and retention strategies. Presented at: Investigator meeting of TB vaccine. Chennai, India; December 2016.
  4. Mave V. RePORT India. Presented at: Common Protocol and TB Vaccine Studies Integration Meeting. Chennai, India; November 2016.
  5. Mave V. Updates on the recombinant BCG vaccine trial in India. Presented at: RePORT International 2016 Annual Meeting. Durban, South Africa; July 2016.
  6. Gupta, A. Conducting HIV and TB research in India: Challenges and opportunities. University of Texas Health Science Center. Tyler, TX, USA; June 23, 2016.
  7. Mave V, Pradhan R, Kagal A, Bharadwaj R, Gupte N, Gupta A, Meshram S, Golub J. Third anti-TB drug in continuation phase for TB patients: Is it the need of the hour for India? Presented at: 47th Union World Conference on Lung Health. Liverpool, UK; October 27, 2016.
  8. Mave V, Gupte N, Meshram S, Kagal A, Gupta A, Bharadwaj R, Pradhan R, Golub J. Xpert® MTB/RIF assay for pulmonary tuberculosis diagnosis in patients with pre-diabetes mellitus and diabetes mellitus. Presented at: 47th Union World Conference on Lung Health. Liverpool, UK; October 27, 2016.
  9. Gupte A, Meshram S, Selvaraju S, Gupte N, Shivakumar SVBY, Paradkar M, Kohli R, Thiruvengadam K, Suryavanshi N, Padmapriyadarsini C, Mave V, Swaminathan S, Gupta A, Golub J, Checkley W. Host factors associated with poor respiratory health-related quality of life in pulmonary tuberculosis. Presented at: IDWeek 2016. New Orleans, LA, USA; October 27, 2016 & RePORT International 2016 Annual Meeting. Durban, South Africa; July 14, 2016.
  10. Padmapriyadarsini C, Mave V, Tiruvengadam K, Gupte N, Hannah LE, Meshram S, Swaminathan S, Gupta A. Household contact tracing of adult pulmonary TB patients in India: Prevalence of TB disease. Presented at: IDWeek 2016. New Orleans, LA, USA; October 27, 2016.
  11. Shivakumar SVBY, Thiruvengadam K, Gupte N, Padmapriyadarsini C, Mave V, Hannah LE, Kulkarni V, Gupte A, DeLuca A, Pattabiraman S, Sharma GN, Pradhan N, Subramaniyan B, Chandrakumar D, Thomas B, Suryavanshi B, Paradkar M, Meshram S, Kagal A, Kohli R, Golub J, Ramachandran G, Swaminathan S, Gupta A. TB infection prevalence, incidence, and risk factors among child and adult household contacts of adult TB cases in India. Presented at: IDWeek 2016. New Orleans, LA, USA; October 27, 2016.
  12. Elf JL, Kinikar A, Khadse S, Mave V, Gupte N, Kulkarni V, Patekar S, Raichur P, Breysse P, Gupta A, Golub J. The association of exposure to air pollution from biomass fuels, kerosene, and secondhand tobacco smoke with TB in adult women and children in Pune, India. Presented at: RePORT International 2016 Annual Meeting. Durban, South Africa; July 14, 2016.
  13. Christopher DJ. Advances in the management of drug resistant TB. Presented at: TB Symposium. Convened by Krishna Medical College in collaboration with McGill University (Canada). Manipal, India; December 21, 2016.
  14. Christopher DJ. Healthcare worker TB: A Panel Discussion. Presented at: TB Symposium. Convened by Krishna Medical College in collaboration with McGill University (Canada). Manipal, India; December 21, 2016.
  15. Christopher DJ. Evolution of drug resistant TB in India. Presented at: Annual Update in Tuberculosis. Convened by CMC Vellore. Vellore, India; November 19, 2016.
  16. Christopher DJ. Screening for LTBI in healthcare personnel to assess TB risk—Lessons from India. Presented at: 5th Meeting of Asian Experts Community. Taipei, Taiwan; August 26–28, 2016.
  17. Christopher DJ. TB risk in healthcare workers: Myth or reality? Presented at: RePORT International 2016 Meeting. Durban, South Africa; July 14–15, 2016.
  18. Christopher DJ. From lab to clinic: Optimizing the importance of new diagnostics. Presented at: Advancing TB Research—An Exploration of Opportunities. Convened by PD Hinduja Hospital and NIH (USA). Mumbai, India; March 23–24, 2016.
  19. Christopher DJ. Lessons from healthcare—TB research in India. Presented at: CMC Winter Symposium and the RePORT India 2016 Joint Leadership Group Meeting. Vellore, India; February 12–13, 2016.
  20. Christopher DJ. Pleural tuberculosis. Presented at: Association of Physicians of India Meeting. Hyderabad, India; January 29–31, 2016.
  21. Christopher DJ, Balamugesh T, Dhabi P. The prevalence of active and latent tuberculosis infection in patients with type 2 diabetes mellitus in a tertiary care hospital of South India. Presented at: RePORT India 2016 Joint Leadership Meeting. Vellore, India; February 12–14, 2016.
  22. Christopher DJ, Balamugesh T, Rohit KO, James P, Gupta R. Diagnostic yield of various microbiologic and histopathologic tests in TB pleural effusion diagnosed with thoracoscopy and outcomes of such patients on 6 months follow up. Presented at: RePORT India 2016 Joint Leadership Meeting. Vellore, India; February 12–14, 2016.
  23. Svadzian A, Sahu A, Pleskunas JA, Sarkar S, Roy G, Ellner JJ, Hochberg NS, Reddy D. Association between wood fuel usage and disease severity among pulmonary tuberculosis cases. Presented at: American Society of Tropical Medicine & Hygiene Meeting. Atlanta, GA, USA; November 2016.
  24. Stigma as a barrier to tuberculosis care: A literature review. Presented at: Evans Department of Medicine Research Days, Boston University School of Medicine. Boston, MA, USA; October 2016.
  25. Roy G, Sivaprakasam A, Kubiak R, Govindarajan S, Salgame P, Ellner J, Hochberg N, Sarkar S. Description of new pulmonary tuberculosis cases in Southern India. Presented at: Evans Department of Medicine Research Days, Boston University School of Medicine. Boston, MA, USA; October 2016.
  26. Svadzian A, Sahu A, Pleskunas JA, Sarkar S, Roy G, Ellner JJ, Hochberg NS, Reddy D. Association between wood fuel usage and disease severity among pulmonary tuberculosis cases. Poster presented at: Evans Department of Medicine Research Days, Boston University School of Medicine. Boston, MA, USA; October 2016.
  27. Conversion among pulmonary tuberculosis cases in India. Presented at: Evans Department of Medicine Research Days, Boston University School of Medicine. Boston, MA, USA; October 2016.
  28. Predictors of 2 month sputum conversion among tuberculosis patients in India. Presented at: Evans Department of Medicine Research Days, Boston University School of Medicine. Boston, MA, USA; October 2016.
  29. Prolonged cough among tuberculosis patients in Tamil Nadu and Pondicherry, India. Presented at: Evans Department of Medicine Research Days, Boston University School of Medicine. Boston, MA, USA; October 2016.
  30. Reddy D, Sahu S, Roy G, Ellner JJ, Horsburgh Jr CR, Pleskunas JA, Sarkar S, Hochberg NS. Association between biomass fuel, tobacco use and two-month sputum smear conversion among pulmonary tuberculosis cases in India. Presented at: American Thoracic Society Conference. San Francisco, CA, USA; May 2016.
  31. Kornfeld H. Tuberculosis and diabetes: From bench to bedside and back. Presented at: Workshop on Integrated Care and Research for Tuberculosis, Diabetes, and HIV/AIDS: Challenges, Strategies, and Clinical Solutions. NIAID, International Union for Tuberculosis and Lung Disease, Bill and Melinda Gates Foundation. Liverpool, UK.; October 24, 2016.
  32. Kornfeld H. Diabetic immunopathy. Presented at: Boston University School of Medicine Inflammation Symposium. Boston, MA, USA; May 23, 2016.
  33. Kornfeld H. Developing a comprehensive therapeutic research strategy for the converging epidemics of TB, T2DM, and HIV. Co-Organizer and Speaker. NIAID Workshop. Rockville, MD, USA; May 10–11, 2016.
  34. Kornfeld H. Workshop on advancing TB research: TB, diabetes, and host-directed therapies. Presented at: P.D. Hinduja Hospital. Mumbai, India; April 23–24, 2016.
  35. Kornfeld H. The impact of Mycobacterium tuberculosis immune evasion on protective immunity: Implications for TB vaccine design. Co-Organizer, NIAID TB Workshop. Rockville, MD, USA; March 7–8, 2016.
  36. Kornfeld H. Symposium on Tuberculosis Co-Morbidities & Immunopathogenesis. Organizer and Speaker, Keystone, CO, USA; February 28–March 2, 2016.
  37. Kornfeld H. Sugar, fat, and consumption. Presented at: Pulmonary Center, Boston University School of Medicine. Boston, MA, USA; January 16, 2016.
  38. Udwadia ZF, Tornheim JA, Ganatra S, DeLuca A, Banka R, Gupta A. Impact of drug susceptibility testing on drug choice in a tuberculosis cohort with high rates of drug resistance from the private sector in Mumbai. Presented at: IDWeek 2016. New Orleans, LA, USA; October 27, 2016.
  39. Gupta A. An Overview of the RePORT India Consortium. Presented at: Annual IeDEA Meeting; National Institutes of Health. June 22, 2016; Rockville, MD, USA.
Year 2015
  1. Cheekatla SS, Venkatasubramanian S, Tripathi D, Paidipally P, Welch E, Tvinnereim AR, Vankayalapati R. IL-21 is essential for the optimal control of Mycobacterium tuberculosis infection. Presented at: American Association of Immunologist Meeting. New Orleans, LA, USA. May 8–12, 2015.
  2. Cheekatla SS, Tripathi D, Venkatasubramanian S, Paidipally P, Welch E, Tvinnereim AR, Kornfeld H, Vankayalapati R. IL-6 regulates pro- and anti-inflammatory cytokine production and mortality of Mycobacterium tuberculosis infected Type 2 diabetic mice. Presented at: American Association of Immunologists Meeting. New Orleans, LA, USA. May 8–12, 2015.
  3. Tripathi D, Venkatasubramanian S, Cheekatla SS, Paidipally P, Welch E, Tvinnereim AR, Vankayalapati R. CD4+CD25+Foxp3+ cells from JNK-/- mice prolong pancreatic allograft survival in type 1 diabetic Mice. Presented at: American Association of Immunologist Meeting. New Orleans, LA, USA. May 8–12, 2015.
  4. Tripathi D, Venkatasubramanian S, Cheekatla SS, Paidipally P, Welch E, Tvinnereim AR, Vankayalapati R. Liver NK1.1 cells and IL-22 promote pancreatic islets allograft survival in type 1 diabetic mice. Presented at: American Association of Immunologists Meeting New Orleans, LA, USA. May 8–12, 2015.
  5. Venkatasubramanian S, Dhiman R, Paidipally P, Cheekatla SS, Tripathi D, Welch E, Tvinnereim AR, Brenda Jones B, Theodorescu D, Barnes PF, Vankayalapati R. A rho GDP dissociation inhibitor produced by apoptotic T-cells inhibits growth of Mycobacterium tuberculosis. Presented at: American Association of Immunologists Meeting. New Orleans, LA, USA. May 8–12, 2015.
  6. Venkatasubramanian S, Paidipally P, Cheekatla SS, Welch E, Raghunath A, Tvinnereim AR, Nurieva R, Barnes PF, Vankayalapati R. IL-21 dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis. Presented at: NK 2015—15th Meeting of the Society for Natural Immunity. Montebello, Canada; May 2-6, 2015.
  7. Gupta, A. Conducting HIV and TB research in India: Challenges and opportunities. Emory University. Atlanta, GA, USA; August 27, 2015.
  8. Mave V. Therapeutic drug monitoring (TDM) of TB in young children: The role of hair assays. Presented at: IMPAACT Network Annual Meeting. Washington DC, USA; June 2015.
  9. Mave V. RePORT India: Objectives and future directions. Presented at: TB Vaccine 4th Global Forum. Shanghai, China; April 2015.
  10. Ogale YP, Elf JL, Lokhande R, Mave V, Roy S, Gupta A, Golub JE, Mathad J. Characteristics associated with mobile phone access among TB patients in Pune, India. Presented at: 46th World Conference on Lung Health. Cape Town, South Africa; December 1–5, 2015.
  11. Elf JL, Kinikar A, Khadse S, Mave V, Gupte N, Kulkarni V, Patekar S, Raichur P, Breysse P, Gupta A, Golub J. The association of exposure to air pollution from biomass fuels, kerosene, and secondhand tobacco smoke with TB in adult women and children in Pune, India. Presented at: American Thoracic Society International Conference. Denver, CO, USA; May 1, 2015.
  12. Christopher DJ. TB in healthcare workers. Presented at: National Update in Respiratory Medicine. Convened by PD Hinduja Hospital. Mumbai, India; November 27–29, 2015.
  13. Christopher DJ. Road for TB elimination in India. Presented at: 4th Meeting of Asian Experts Community. Bali, Indonesia; August 7–9, 2015.
  14. Roy G, Sivaprakasam A, Kubiak R, Govindarajan S, Salgame P, Ellner J, Hochberg N, Sarkar S. Description of new pulmonary tuberculosis cases in Southern India. Presented at: 46th Union World Conference on Lung Health. Cape Town, South Africa; December 1–5, 2015.
  15. Sarkar S, Fernandes P, Lakshminarayanan S, Kubiak R, Horsburgh CR, Ravikumar T, Ellner J, Hochberg N. Age and gender distribution of latent tuberculosis infection cases in a household contact study, India. Presented at: 46th Union World Conference on Lung Health. Cape Town, South Africa; December 1–5, 2015.
  16. Reddy, D, Sahu S, McIntosh A, Kubiak R, Roy G, Ellner J, Sarkar S, Hochberg N. Association between latent tuberculosis infection and indoor air pollution among household contacts of pulmonary tuberculosis cases. Poster presented at: 46th Union World Conference on Lung Health of the International Union Against TB and Lung Disease. Cape Town, South Africa; December 1–5, 2015.
  17. Kornfeld H. Environmental epigenetics—Diabetes and tuberculosis. Presented at: Joint Retreat for the Centres for Biodiscovery & Molecular Development of Therapeutics and Biosecurity and Tropical Infectious Diseases (Australian Institute of Tropical Health & Medicine). Port Townsend, Australia; September 22, 2015.
  18. Kornfeld H. Determinants of TB severity. Presented at: Shenzhen-Hong Kong Institute of Infectious Diseases. Shenzhen, China; November 20, 2015.
  19. Kornfeld H. Tuberculosis: The rise of comorbidities. Presented at: Medical Grand Rounds. University of Massachusetts Medical School. Worcester, MA, USA; June 4, 2015.
  20. Kornfeld H. TB and diabetes. Presented at: Singapore Immunology Network. Singapore; February 27, 2015.
  21. Kornfeld H. Keystone Symposium on Granulomas in Infectious and Non-Infectious Disease: TB and Diabetes. Invited speaker, Santa Fe, NM, USA; January 22–27, 2015.
  22. Kornfeld H. The effects of diabetes on TB susceptibility. Presented at: No.4 People’s Hospital of Nanning. Nanning, China; January 12, 2015.
  23. Mave V. RePORT India: Objectives and future directions. Presented at: TB Vaccine 4th Global Forum. Shanghai, China; 2015
Year 2014
  1. Christopher DJ. Newer diagnostics in TB. Presented at: Institute of Thoracic Medicine, MMC, CME Program for the PG Students of Southern States. Chennai, India; September 2014.
  2. Christopher DJ. Relevance of TST and IGRA in current day practice. Presented at: ASHRAICON Conference 2014. Ahmedabad, India; July 27, 2014.
  3.  Christopher DJ, Mitra S, Saroini JS, Balaji V, Gupta M, Therese M, Yadav B, Jeyaseelan L. Burden of diabetes among patients with tuberculosis: Ten-year experience from an Indian tertiary care teaching hospital. Presented at: 45th Union World Conference on Lung Health. Barcelona, Spain; October 28–November 1, 2014.
  4. Christopher DJ, Denkinger C, Thangakunam B, Sarojini JS, Pai M, Schumacher S. Point-of-care implementation of Xpert: Evaluating the impact of product and process innovation in TB diagnosis. Presented at: 45th Union World Conference on Lung Health. Barcelona, Spain; October 28–November 1, 2014.
  5. Kornfeld H. Sugar, fat, and consumption. Presented at: University of Texas, Health Science Center at Tyler. Tyler, TX, USA; August 22, 2014.
  6. Hamilton CD, Ellner J, Swaminathan S, Christopher D, Gupta A, Sterling T, Rolla VC, Stoszek S. Regional Prospective Observational Research for Tuberculosis (RePORT) Consortia using a common protocol to collect specimens for biomarker research. Poster presented at: 45th Union World Conference on Lung Health of the International Union Against TB and Lung Disease. Barcelona, Spain; October 28–November 1, 2014.